Original article: General thoracic
Role of lung reduction in lung transplant candidates with pulmonary emphysema

https://doi.org/10.1016/0003-4975(96)00535-8Get rights and content

Background.

The average waiting time for candidates for lung transplantation (LTx) with end-stage emphysema is 21 months with a 15% mortality. We hypothesized that lung reduction might offer an alternative to LTx.

Methods.

Of 95 patients with end-stage emphysema evaluated by our LTx program, 45 were accepted for both lung reduction and LTx and 35 underwent lung reduction.

Results.

All 35 patients survived lung reduction. Thirty patients had a follow-up of 3 months. There was a significant improvement (p < 0.05) of forced expiratory volume in 1 second (0.64 to 0.97 L), forced vital capacity (2.12 to 2.76 L), residual volume (5.62 to 4.26 L), maximum voluntary ventilation (28.1 to 38.5 L/min), 6-minute walk (904 to 1, 012 feet), Borg dyspnea index (3.7 to 2.4), and arterial carbon dioxide tension (44.9 to 41.6 mm Hg). Twenty patients (66%) were removed from the LTx list due to their significant improvement (group A). Compared with the remaining 10 patients with 3 months of follow-up (group B), percent increase in forced expiratory volume in 1 second (70% in group A versus 27% in group B) and in forced vital capacity (41% group A versus 18% group B) and percent decrease in residual volume (26% group A versus 1.5% group B) were significantly better in group A (p < 0.01). Seven patients in group B were bridged to LTx; 6 of these patients (86%) had hypercarbia before lung reduction compared with 8 (40%) in group A (p < 0.05). All are alive after LTx: the forced expiratory volume in 1 second is 53% and the forced vital capacity is 64% of predicted.

Conclusions.

Lung reduction is safe and effective in selected LTx candidates with end-stage emphysema and has the potential to provide an alternative to LTx. Longterm follow-up is warranted to confirm these results.

References (24)

  • HaydenA et al.

    Primary diagnosis predicts prognosis of lung transplant candidates

    Transplantation

    (1993)
  • BrantiganO et al.

    Surgical treatment of pulmonary emphysema

    Am Surg

    (1957)
  • Cited by (34)

    • Outcomes of lung volume reduction surgery followed by lung transplantation: A matched cohort study

      2002, Annals of Thoracic Surgery
      Citation Excerpt :

      A search of the University of Pittsburgh Lung Transplant Candidate Registry was performed using the search terms thoracotomy, thoracoscopic, lung reduction, and emphysema. Our selection criteria for candidacy for LTx and LVRS and our evaluation protocols at the University of Pittsburgh have been published previously [7]. Criteria for selection of patients for LTx after LVRS included (1) a postbronchodilator FEV1 less than 30% predicted with evidence of a rapid decline in pulmonary function over time or a decline in functional status or an increase in the frequency of exacerbations; (2) requirement for supplemental oxygen at rest; (3) New York Heart Association functional class 3 or 4 dyspnea or class 2 dyspnea with an elevated arterial carbon dioxide tension;, (4) hypercarbia; (5) signs of secondary pulmonary hypertension; and (6) aged 65 years or less.

    • Lung volume reduction surgery

      2000, Current Problems in Surgery
    • Surgical treatment of chronic obstructive pulmonary disease

      1999, American Journal of the Medical Sciences
    View all citing articles on Scopus

    Presented at the Poster Session of the Thirty-second Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 29–31, 1996.

    View full text